Capital Investment Strategy

CHALLENGES

Private equity and venture capital firms investing in life science and health organizations face the following challenges, among others:

• Understand the underlying technologies.
• Navigate the minefields of developing a product in a highly regulated environment.
• Manage a syndicate of investors who have very different agendas and strategies.

SCIENTIA KNOW-HOW

With over 30 years of experience in developing strategies to build successful companies, Scientia has become a trusted resource for all diversified and sector specific funds investing in the life science and healthcare industries. We approach each situation with a standardized process, but because we understand the venture/private equity mindset, we focus on the core issues that are important in making an investment decision. Additionally, our focus on both multinationals and emerging companies results in unique insights when advising capital investors.

The strategy services we provide to venture capital and private equity the investors include:

• Due Diligence
• Investment Portfolio
• Exit Strategy

To learn more about Scientia’s Capital Investment strategy capabilities for Venture Capital/Private Equity, please contact us.